Zhang Yun-Qian, Liu Yu-Jian, Mao Yan-Fei, Dong Wen-Wen, Zhu Xiao-Yan, Jiang Lai
Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, PR China; Department of Physiology and The Key Laboratory of Molecular Neurobiology of Ministry of Education, Second Military Medical University, Shanghai 200433, PR China.
Department of Physiology and The Key Laboratory of Molecular Neurobiology of Ministry of Education, Second Military Medical University, Shanghai 200433, PR China.
Clin Nutr. 2015 Aug;34(4):752-60. doi: 10.1016/j.clnu.2014.08.014. Epub 2014 Sep 6.
BACKGROUND & AIMS: Fibrotic changes seem to be responsible for the high mortality rate observed in patients with acute respiratory distress syndrome (ARDS). The present study aimed to determine whether resveratrol, a natural antioxidant polyphenol, had anti-fibrotic effects in the murine model of lipopolysaccharide (LPS)-induced pulmonary fibrosis.
Fibrosis was assessed by determination of collagen deposition, hydroxyproline and type I collagen levels in lung tissues. Development of epithelial-mesenchymal transition (EMT) was identified by the loss of E-cadherin accompanying by the acquisition of α-smooth muscle actin (α-SMA). Transforming growth factor (TGF)-β1 content, levels of phosphorylated Smad2/Smad3 and Smad4, malondialdehyde (MDA) content, total antioxidant capacity (T-AOC), superoxide dismutase (SOD) activity, and catalase (CAT) activity in lung tissues were determined.
LPS increased collagen deposition, hydroxyproline and type I collagen contents, and meanwhile induced EMT process, stimulated TGF-β1 production and Smad activation in lung tissues on day 21 to day 28 after LPS administration. In addition, LPS treatment resulted in a rapid induction of oxidative stress as evidenced by increase of MDA and decreases of T-AOC, CAT and SOD activities as early as 7 days after LPS treatment, which was persistent for at least 4 weeks. In contrast, resveratrol treatment attenuated LPS-induced EMT and pulmonary fibrosis, meanwhile it suppressed LPS-induced oxidative stress, TGF-β1 production and activation of Smad signaling pathway.
Resveratrol may ameliorate LPS-induced EMT and pulmonary fibrosis through suppression of oxidative stress and TGF-β1/Smad signaling pathway. Application of antioxidants may represent a useful adjuvant pharmacologic approach to reduce ARDS-associated pulmonary fibrosis.
纤维化改变似乎是急性呼吸窘迫综合征(ARDS)患者高死亡率的原因。本研究旨在确定天然抗氧化多酚白藜芦醇在脂多糖(LPS)诱导的小鼠肺纤维化模型中是否具有抗纤维化作用。
通过测定肺组织中的胶原沉积、羟脯氨酸和I型胶原水平来评估纤维化。上皮-间质转化(EMT)的发生通过E-钙黏蛋白的丢失并伴随α-平滑肌肌动蛋白(α-SMA)的获得来确定。测定肺组织中转化生长因子(TGF)-β1含量、磷酸化Smad2/Smad3和Smad4水平、丙二醛(MDA)含量、总抗氧化能力(T-AOC)、超氧化物歧化酶(SOD)活性和过氧化氢酶(CAT)活性。
LPS给药后第21天至第28天,LPS增加了胶原沉积、羟脯氨酸和I型胶原含量,同时诱导了EMT过程,刺激了肺组织中TGF-β1的产生和Smad激活。此外,LPS治疗导致氧化应激迅速诱导,早在LPS治疗后7天,MDA增加以及T-AOC、CAT和SOD活性降低就证明了这一点,这种情况持续至少4周。相比之下,白藜芦醇治疗减轻了LPS诱导的EMT和肺纤维化,同时抑制了LPS诱导的氧化应激、TGF-β1产生和Smad信号通路的激活。
白藜芦醇可能通过抑制氧化应激和TGF-β1/Smad信号通路来改善LPS诱导的EMT和肺纤维化。应用抗氧化剂可能是一种有用的辅助药物方法,以减少与ARDS相关的肺纤维化。